We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Our mission in Biomendex is to change the way bone voids are treated. We believe that delivering versatile and better working medical devices to operating theaters is an essential factor in improving surgical outcomes and minimizing the operational risks in bone regeneration. We believe in freedom to operate.
We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Our mission in Biomendex is to change the way bone voids are treated. We believe that delivering versatile and better working medical devices to operating theaters is an essential factor in improving surgical outcomes and minimizing the operational risks in bone regeneration. We believe in freedom to operate.
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- 2018
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Korkeakoulunkatu 1 West and Inner Finland Hervanta
- City
- Tampere
- Region
- Pirkanmaa
- Postal Code
- 33720
- Country
- Finland